Bhakta Avinash, Tafen Marcel, Ahmed Mushfique, Ata Ashar, Abraham Christa, Bruce David, Valerian Brian T, Lee Edward C
Department of Surgery, Albany Medical College, Albany, New York.
Dis Colon Rectum. 2014 Dec;57(12):1379-83. doi: 10.1097/DCR.0000000000000257.
Inflammatory bowel disease confers a hypercoagulable state. A large number of these patients require central venous access in the form of peripherally inserted central catheters for long-term intravenous therapies. Our clinical observations suggested that these patients had a higher incidence of catheter-associated deep venous thrombosis than that of the general population.
The aim of this study was to examine the relationship between IBD and catheter-associated deep venous thrombosis.
A retrospective chart review was conducted of all patients who underwent peripherally inserted central catheter line placement between 2009 and 2011.
This study was performed at a single-institution tertiary referral center.
All patients who underwent peripherally inserted central catheter line placement were identified.
The risk of catheter-associated deep venous thrombosis in IBD patients was assessed. This risk was compared with known risk factors such as malnutrition, malignancy, diabetes mellitus, and tobacco use. Multivariate analysis was performed. Catheter size, indication for placement, and vein location of catheter-associated deep venous thrombosis were identified in the IBD population.
There were 7179 peripherally inserted central catheter lines placed during the study period; the overall incidence of catheter-associated deep venous thrombosis was 2.1% (148/7179). The incidence of catheter-associated deep venous thrombosis among patients with IBD was 6.8% (9/132). The incidence of catheter-associated deep venous thrombosis among non-IBD patients was 1.9% (139/7047) (relative risk, 3.5; 95% CI, 1.8-6.6; p < 0.001). The incidence of catheter-associated deep venous thrombosis was increased for patients with malnutrition (4.8%, 30/628, p < 0.001) and increasing age (95% CI, 1.01-1.12; p = 0.02). There was no increased incidence of catheter-associated deep venous thrombosis for patients with diabetes mellitus (1.6%, 25/1574, p < 0.14), malignancy (2.8%, 30/1041, p = 0.06), or tobacco use (1.6%, 31/1938, p = 0.10). After multivariate analysis, IBD, malnutrition, and increasing age were found to be significant risk factors for the development of catheter-associated deep venous thrombosis.
The inability to track the number of catheter days, the inaccuracy of administrative data, the lack of outpatient follow-up, and the small number of events in the study cohort were limitations of this study.
This is the first study to demonstrate IBD as an independent risk factor to the development of catheter-associated deep venous thrombosis. The placement of a peripherally inserted central catheter line in IBD should be utilized selectively.
炎症性肠病会导致血液高凝状态。这些患者中有很大一部分需要通过外周静脉穿刺中心静脉置管的方式进行中心静脉通路建立,以接受长期静脉治疗。我们的临床观察表明,这些患者发生导管相关深静脉血栓形成的几率高于普通人群。
本研究旨在探讨炎症性肠病与导管相关深静脉血栓形成之间的关系。
对2009年至2011年间所有接受外周静脉穿刺中心静脉置管的患者进行回顾性病历审查。
本研究在一家单机构三级转诊中心进行。
确定所有接受外周静脉穿刺中心静脉置管的患者。
评估炎症性肠病患者发生导管相关深静脉血栓形成的风险。将该风险与营养不良、恶性肿瘤、糖尿病和吸烟等已知风险因素进行比较。进行多因素分析。确定炎症性肠病患者中导管相关深静脉血栓形成的导管尺寸、置管指征和静脉位置。
研究期间共放置了7179根外周静脉穿刺中心静脉导管;导管相关深静脉血栓形成的总体发生率为2.1%(148/7179)。炎症性肠病患者中导管相关深静脉血栓形成的发生率为6.8%(9/132)。非炎症性肠病患者中导管相关深静脉血栓形成的发生率为1.9%(139/7047)(相对风险为3.5;95%可信区间为1.8 - 6.6;p < 0.001)。营养不良患者(4.8%,30/628,p < 0.001)和年龄增长(95%可信区间为1.01 - 1.12;p = 0.02)时,导管相关深静脉血栓形成的发生率增加。糖尿病患者(1.6%,25/1574,p < 0.14)、恶性肿瘤患者(2.8%,30/1041,p = 0.06)或吸烟者(1.6%,31/1938,p = 0.10)中导管相关深静脉血栓形成的发生率未增加。多因素分析后发现,炎症性肠病、营养不良和年龄增长是发生导管相关深静脉血栓形成的重要危险因素。
无法追踪导管留置天数、管理数据不准确、缺乏门诊随访以及研究队列中的事件数量较少是本研究的局限性。
这是第一项证明炎症性肠病是导管相关深静脉血栓形成独立危险因素的研究。在外周静脉穿刺中心静脉置管时,炎症性肠病患者应选择性使用。